NCT00384917View on ClinicalTrials.gov

Study to Determine the Impact of Multiple Doses of Ketoconazole on Single-Dose Pharmacokinetics of HCV-796

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2006

Study Completion Date

September 30, 2006

Conditions
Healthy
Interventions
DRUG

Ketoconazole

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00384917 - Study to Determine the Impact of Multiple Doses of Ketoconazole on Single-Dose Pharmacokinetics of HCV-796 | Biotech Hunter | Biotech Hunter